AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Sotera Health Company Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Sotera Health Company furnished a press release reporting its financial results for the quarter ended June 30, 2025 and scheduled a conference call at 9:00 a.m. Eastern Time to discuss those results. The press release is attached to the Form 8-K as Exhibit 99.1 and is incorporated by reference into the report.

The filing clarifies that the press release and related information are being furnished, not filed, and therefore are not subject to Section 18 liability. This Form 8-K does not include any financial figures or performance metrics; readers should consult the attached Exhibit 99.1 for the detailed results and disclosures.

Sotera Health Company ha fornito un comunicato stampa con i risultati finanziari per il trimestre chiuso al 30 giugno 2025 e ha programmato una conference call alle 9:00 a.m., ora orientale per illustrare tali risultati. Il comunicato è allegato al Modulo 8-K come Allegato 99.1 ed è incorporato per riferimento nel rapporto.

La documentazione precisa che il comunicato e le informazioni correlate sono forniti e non depositati, pertanto non sono soggetti alla responsabilità prevista dalla Sezione 18. Questo Modulo 8-K non contiene cifre finanziarie né indicatori di performance; i lettori devono consultare l'Allegato 99.1 per i risultati e le informazioni dettagliate.

Sotera Health Company suministró un comunicado de prensa con sus resultados financieros del trimestre concluido el 30 de junio de 2025 y programó una conferencia telefónica a las 9:00 a.m., hora del Este para comentar dichos resultados. El comunicado se adjunta al Formulario 8-K como Anexo 99.1 y se incorpora por referencia en el informe.

La presentación aclara que el comunicado y la información relacionada se están facilitando y no presentando, por lo que no están sujetos a la responsabilidad conforme a la Sección 18. Este Formulario 8-K no incluye cifras financieras ni métricas de desempeño; los lectores deben consultar el Anexo 99.1 adjunto para los resultados y las divulgaciones detalladas.

Sotera Health CompanyëŠ� 2025ë…� 6ì›� 30ì�ë¡� 종료ë� 분기ì� 재무 ê²°ê³¼ë¥� 알리ëŠ� ë³´ë„ìžë£Œë¥� 제공했으ë©�, 해당 ê²°ê³¼ë¥� ë…¼ì˜í•˜ê¸° 위해 ë™ë¶€ 시간 기준 오전 9ì‹�ì—� 컨í¼ëŸ°ìФ ì½œì„ ì˜ˆì •í–ˆìŠµë‹ˆë‹¤. ë³´ë„ìžë£ŒëŠ� Form 8-Kì� Exhibit 99.1ë¡� 첨부ë˜ì–´ ë³� ë³´ê³ ì„œì— ì°¸ì¡°ë¡� í¬í•¨ë˜ì–´ 있습니다.

해당 제출서류ëŠ� ë³´ë„ìžë£Œ ë°� ê´€ë � ì •ë³´ê°€ 제출(furnished)ë� 것ì´ì§€ ì‹ ê³ (filed)ë� ê²ƒì´ ì•„ë‹ˆë¯€ë¡� Section 18ì—� 따른 ì±…ìž„ 대ìƒì´ 아님ì� 명확íž� 합니ë‹�. ì� Form 8-Kì—는 재무 수치ë‚� 성과 지표가 í¬í•¨ë˜ì–´ 있지 않습니다; ìƒì„¸í•� ê²°ê³¼ ë°� 공시ëŠ� 첨부ë� Exhibit 99.1ì� 참조하시ê¸� ë°”ëžë‹ˆë‹¤.

Sotera Health Company a publié un communiqué de presse faisant état de ses résultats financiers pour le trimestre clos le 30 juin 2025 et a programmé une conférence téléphonique à 9h00, heure de l'Est pour commenter ces résultats. Le communiqué est annexé au formulaire 8-K sous la référence Exhibit 99.1 et est incorporé par renvoi dans le rapport.

Le dépôt précise que le communiqué et les informations connexes sont fournis (furnished) et non déposés (filed), et ne sont donc pas soumis à la responsabilité prévue par la Section 18. Ce formulaire 8-K ne contient aucune donnée financière ni indicateur de performance ; les lecteurs doivent consulter l'Exhibit 99.1 joint pour obtenir les résultats et divulgations détaillés.

Sotera Health Company hat eine Pressemitteilung mit den Finanzergebnissen für das zum 30. Juni 2025 endende Quartal bereitgestellt und eine Telefonkonferenz zur Besprechung dieser Ergebnisse für 9:00 Uhr Eastern Time angesetzt. Die Pressemitteilung ist dem Formular 8-K als Exhibit 99.1 beigefügt und durch Verweis in den Bericht aufgenommen.

Die Einreichung stellt klar, dass die Pressemitteilung und die zugehörigen Informationen bereitgestellt (furnished) und nicht eingereicht (filed) werden und daher nicht der Haftung nach Abschnitt 18 unterliegen. Dieses Formular 8-K enthält keine finanziellen Kennzahlen oder Leistungsmetriken; Leser sollten das beigefügte Exhibit 99.1 für detaillierte Ergebnisse und Angaben heranziehen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine earnings release filing; provides a press release and an investor call but contains no metrics in the Form 8-K itself.

The company has furnished its quarterly results via a press release and scheduled a conference call, which supports timely investor communication. Because the material is furnished rather than filed, the content in this Form 8-K is limited in legal exposure and does not by itself provide the revenue, profit, or cash flow data investors need to assess performance. Investors must review Exhibit 99.1 for the substantive numbers.

TL;DR: A standard disclosure process that preserves governance transparency while limiting Form 8-K liability exposure.

Attaching the press release as Exhibit 99.1 and explicitly stating the furnished-not-filed status is a customary approach to distribute results while noting limited Section 18 liability. The filing shows the company is following disclosure protocols by notifying the market of the release and call, but it does not alter governance, executive responsibilities, or report new board-level actions. Material substance resides in the attached press release.

Sotera Health Company ha fornito un comunicato stampa con i risultati finanziari per il trimestre chiuso al 30 giugno 2025 e ha programmato una conference call alle 9:00 a.m., ora orientale per illustrare tali risultati. Il comunicato è allegato al Modulo 8-K come Allegato 99.1 ed è incorporato per riferimento nel rapporto.

La documentazione precisa che il comunicato e le informazioni correlate sono forniti e non depositati, pertanto non sono soggetti alla responsabilità prevista dalla Sezione 18. Questo Modulo 8-K non contiene cifre finanziarie né indicatori di performance; i lettori devono consultare l'Allegato 99.1 per i risultati e le informazioni dettagliate.

Sotera Health Company suministró un comunicado de prensa con sus resultados financieros del trimestre concluido el 30 de junio de 2025 y programó una conferencia telefónica a las 9:00 a.m., hora del Este para comentar dichos resultados. El comunicado se adjunta al Formulario 8-K como Anexo 99.1 y se incorpora por referencia en el informe.

La presentación aclara que el comunicado y la información relacionada se están facilitando y no presentando, por lo que no están sujetos a la responsabilidad conforme a la Sección 18. Este Formulario 8-K no incluye cifras financieras ni métricas de desempeño; los lectores deben consultar el Anexo 99.1 adjunto para los resultados y las divulgaciones detalladas.

Sotera Health CompanyëŠ� 2025ë…� 6ì›� 30ì�ë¡� 종료ë� 분기ì� 재무 ê²°ê³¼ë¥� 알리ëŠ� ë³´ë„ìžë£Œë¥� 제공했으ë©�, 해당 ê²°ê³¼ë¥� ë…¼ì˜í•˜ê¸° 위해 ë™ë¶€ 시간 기준 오전 9ì‹�ì—� 컨í¼ëŸ°ìФ ì½œì„ ì˜ˆì •í–ˆìŠµë‹ˆë‹¤. ë³´ë„ìžë£ŒëŠ� Form 8-Kì� Exhibit 99.1ë¡� 첨부ë˜ì–´ ë³� ë³´ê³ ì„œì— ì°¸ì¡°ë¡� í¬í•¨ë˜ì–´ 있습니다.

해당 제출서류ëŠ� ë³´ë„ìžë£Œ ë°� ê´€ë � ì •ë³´ê°€ 제출(furnished)ë� 것ì´ì§€ ì‹ ê³ (filed)ë� ê²ƒì´ ì•„ë‹ˆë¯€ë¡� Section 18ì—� 따른 ì±…ìž„ 대ìƒì´ 아님ì� 명확íž� 합니ë‹�. ì� Form 8-Kì—는 재무 수치ë‚� 성과 지표가 í¬í•¨ë˜ì–´ 있지 않습니다; ìƒì„¸í•� ê²°ê³¼ ë°� 공시ëŠ� 첨부ë� Exhibit 99.1ì� 참조하시ê¸� ë°”ëžë‹ˆë‹¤.

Sotera Health Company a publié un communiqué de presse faisant état de ses résultats financiers pour le trimestre clos le 30 juin 2025 et a programmé une conférence téléphonique à 9h00, heure de l'Est pour commenter ces résultats. Le communiqué est annexé au formulaire 8-K sous la référence Exhibit 99.1 et est incorporé par renvoi dans le rapport.

Le dépôt précise que le communiqué et les informations connexes sont fournis (furnished) et non déposés (filed), et ne sont donc pas soumis à la responsabilité prévue par la Section 18. Ce formulaire 8-K ne contient aucune donnée financière ni indicateur de performance ; les lecteurs doivent consulter l'Exhibit 99.1 joint pour obtenir les résultats et divulgations détaillés.

Sotera Health Company hat eine Pressemitteilung mit den Finanzergebnissen für das zum 30. Juni 2025 endende Quartal bereitgestellt und eine Telefonkonferenz zur Besprechung dieser Ergebnisse für 9:00 Uhr Eastern Time angesetzt. Die Pressemitteilung ist dem Formular 8-K als Exhibit 99.1 beigefügt und durch Verweis in den Bericht aufgenommen.

Die Einreichung stellt klar, dass die Pressemitteilung und die zugehörigen Informationen bereitgestellt (furnished) und nicht eingereicht (filed) werden und daher nicht der Haftung nach Abschnitt 18 unterliegen. Dieses Formular 8-K enthält keine finanziellen Kennzahlen oder Leistungsmetriken; Leser sollten das beigefügte Exhibit 99.1 für detaillierte Ergebnisse und Angaben heranziehen.

0001822479FALSE00018224792025-08-082025-08-08

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________
FORM 8-K
_______________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): August 8, 2025
_______________________
SOTERA HEALTH COMPANY
(Exact Name of Registrant as Specified in its Charter)
_______________________
Delaware001-3972947-3531161
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
9100 South Hills Blvd, Suite 300
Broadview Heights, Ohio 44147
(Address of Principal Executive Offices) (Zip Code)
(440) 262-1410
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
_______________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
Trading
Symbol
Name of Exchange
on which registered
Common stock, $0.01 par value per shareSHCThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company   
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
 




Item 2.02. Results of Operations and Financial Condition.
On August 8, 2025, Sotera Health Company (the “Company”) issued a press release (the “Press Release”) announcing its financial results for the quarter ended June 30, 2025. The Company will hold its previously announced conference call on August 8, 2025, at 9:00 a.m. Eastern Time to discuss its financial results for the quarter. A copy of the Press Release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section, and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, unless expressly incorporated by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits  
Exhibit NumberDescription
99.1
Press Release, dated August 8, 2025



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Sotera Health Company
(Registrant)
Date: August 8, 2025By:/s/ Jonathan M. Lyons
Jonathan M. Lyons
Senior Vice President and Chief Financial Officer

FAQ

What did Sotera Health (SHC) disclose in this Form 8-K?

The company furnished a press release announcing its financial results for the quarter ended June 30, 2025 and indicated a conference call will be held to discuss those results.

Is the press release included with the Form 8-K for SHC?

Yes. The press release is attached as Exhibit 99.1 to the Form 8-K and is incorporated by reference.

Does this Form 8-K include financial figures for SHC's quarter?

No. The Form 8-K states the press release announces the results, but the filing itself does not contain any revenue, earnings, or other financial metrics.

When is Sotera Health's conference call to discuss results?

The company indicated a conference call will be held at 9:00 a.m. Eastern Time to discuss the quarter's results.

Is the information in this Form 8-K legally 'filed' under the Exchange Act?

No. The Form 8-K states the press release and related information are being furnished and shall not be deemed 'filed' for purposes of Section 18 of the Exchange Act.
Sotera Health Co

NASDAQ:SHC

SHC Rankings

SHC Latest News

SHC Latest SEC Filings

SHC Stock Data

3.18B
146.92M
2.51%
95.63%
4.82%
Diagnostics & Research
Services-misc Health & Allied Services, Nec
United States
BROADVIEW HEIGHTS